10-K · April 30, 2026
TruBridge's latest 10-K filing provides insights into its strategic vision and ongoing acquisition by IKS Health, which is anticipated to close in Q3 2026. However, the most recent earnings report revealed an EPS of…
Earnings analysis · 10-Q
Filed May 8, 2026 · Our reading of the company's report
The latest report
TruBridge, Inc. reported a slight decrease in total revenue for Q1 2026, totaling $86.3 million, down 1% from $87.2 million in Q1 2025. The diluted EPS for the quarter was $0.03, unchanged from the prior year. Alongside…
TruBridge, Inc. reported a slight decrease in total revenue for Q1 2026, totaling $86.3 million, down 1% from $87.2 million in Q1 2025. The diluted EPS for the quarter was $0.03, unchanged from the prior year. Alongside a notable drop in operating income, performance varied across business segments, with Financial Health revenues declining while Patient Care revenues increased due to new SaaS contract growth and increased migration to SaaS models.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Total revenue was $86.3 million, a decrease of 1% from $87.2 million in Q1 2025.
Diluted EPS remained flat at $0.03 compared to the same quarter last year.
Patient Care revenues grew by 6%, reaching $33.0 million, driven by new SaaS contracts.
Net cash provided by operating activities increased by $9.7 million to $15.5 million in Q1 2026.
Total costs of revenue decreased by $1.2 million and improved as a percentage of revenue, to 44%.
Cash and cash equivalents rose to $35.4 million from $24.9 million at the end of 2025.
Actual EPS was -$0.37 vs estimated EPS of $0.51, missing expectations by 1.73%.
Financial Health revenues fell by 5% to $53.3 million due to customer attrition.
The proposed merger with IKS may not complete, creating uncertainty and operational disruption.
No explicit forward guidance provided in the filing.
TruBridge's latest 10-K filing provides insights into its strategic vision and ongoing acquisition by IKS Health, which is anticipated to close in Q3 2026. However, the most recent earnings report revealed an EPS of…
TruBridge reported 2025 revenue of $346.8 million (an increase of $4.6 million, or 1%, versus 2024) and turned profitable with net income of $4.4 million (EPS $0.29) after a 2024 net loss of $20.9 million. The business…
TruBridge reported 2024 revenue of $342.6M (up 2.0% YoY) driven by Financial Health, while Patient Care revenues declined after the sale of AHT. Operating income turned positive at $6.6M and operating cash flow improved…
TruBridge reported Q3 revenue of $83,830 (in thousands), up $1,118 from $82,712 in the prior-year quarter, driven by Financial Health growth. Operating income improved to $1,944 (in thousands) from an operating loss of…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.